Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands) (GNK) Analysts See $-0.27 EPS; Mengis Capital Management Lifted Its Regeneron Pharmaceutic Com (REGN) Holding

October 10, 2017 - By Maria Brooks

Mengis Capital Management Inc increased Regeneron Pharmaceutic Com (REGN) stake by 46.38% reported in 2017Q2 SEC filing. Mengis Capital Management Inc acquired 705 shares as Regeneron Pharmaceutic Com (REGN)’s stock rose 21.24%. The Mengis Capital Management Inc holds 2,225 shares with $1.09M value, up from 1,520 last quarter. Regeneron Pharmaceutic Com now has $49.69B valuation. The stock declined 1.23% or $5.79 reaching $463.77 on the news. About 210,183 shares traded. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has risen 17.40% since October 10, 2016 and is uptrending. It has outperformed by 0.70% the S&P500.

Analysts expect Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands) (NYSE:GNK) to report $-0.27 EPS on November, 1.They anticipate $3.53 EPS change or 92.89% from last quarter’s $-3.8 EPS. After having $-0.36 EPS previously, Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands)’s analysts see -25.00% EPS growth. About 21,496 shares traded. Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands) (NYSE:GNK) has risen 104.62% since October 10, 2016 and is uptrending. It has outperformed by 87.92% the S&P500.

Since May 12, 2017, it had 1 insider buy, and 7 selling transactions for $42.75 million activity. $1.35 million worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares were sold by BROWN MICHAEL S. $65.06M worth of stock was bought by Sanofi on Friday, June 2. VAGELOS P ROY sold $4.26M worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) on Thursday, May 25. $482,550 worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was sold by GOLDSTEIN JOSEPH L. STAHL NEIL sold 2,812 shares worth $1.35M. $9.90M worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was sold by Terifay Robert J on Thursday, June 15.

Investors sentiment increased to 1.38 in Q2 2017. Its up 0.12, from 1.26 in 2017Q1. It improved, as 42 investors sold REGN shares while 157 reduced holdings. 84 funds opened positions while 190 raised stakes. 71.53 million shares or 1.38% more from 70.55 million shares in 2017Q1 were reported. Tiaa Cref Ltd Liability accumulated 485,336 shares. Fiera stated it has 0.01% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Advisor Lc owns 1,673 shares for 0.19% of their portfolio. Rhenman Prns Asset invested 1.06% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Meeder Asset Inc invested 0.06% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Public Sector Pension Investment Board, Quebec – Canada-based fund reported 8,597 shares. Polar Llp reported 98,763 shares. Jnba Advsr invested in 0% or 3 shares. Aviva Public Ltd Company stated it has 49,936 shares or 0.14% of all its holdings. Clearbridge Invests Ltd Com, a New York-based fund reported 730,571 shares. Acadian Asset Mngmt Ltd Limited Liability Company invested 0% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Parkwood Limited Liability Corporation holds 597 shares or 0.04% of its portfolio. Pnc Fincl Serv Grp Inc accumulated 0.01% or 23,678 shares. Wellington Group Inc Limited Liability Partnership accumulated 5.54M shares or 0.64% of the stock. Pictet Asset Management Limited accumulated 0.47% or 331,247 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com